Trust Point Inc. Celcuity Inc. Transaction History
Trust Point Inc.
- $1.1 Trillion
- Q1 2025
A detailed history of Trust Point Inc. transactions in Celcuity Inc. stock. As of the latest transaction made, Trust Point Inc. holds 17,247 shares of CELC stock, worth $179,023. This represents 0.02% of its overall portfolio holdings.
Number of Shares
17,247
Previous 17,847
3.36%
Holding current value
$179,023
Previous $234 Million
25.36%
% of portfolio
0.02%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding CELC
# of Institutions
98Shares Held
30.6MCall Options Held
16.2KPut Options Held
51.9K-
Baker Bros. Advisors LP New York, NY4.26MShares$44.2 Million0.51% of portfolio
-
Bvf Inc San Francisco, CA3.47MShares$36 Million1.54% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.57MShares$26.7 Million2.15% of portfolio
-
Perceptive Advisors LLC New York, NY2.36MShares$24.5 Million1.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.67MShares$17.4 Million0.0% of portfolio
About Celcuity Inc.
- Ticker CELC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 14,941,300
- Market Cap $155M
- Description
- Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...